Myrexis Inc.

Industry · 15 registered clinical trials.

Status	Trial	Phase	Started
Completed	Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme Glioblastoma Multiforme	Phase 2	2010-12-01
Terminated	A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to HIV Infections	Phase 2	2009-11-01
Completed	Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments Cancer	Phase 1	2009-06-01
Completed	Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme Glioblastoma Multiforme	Phase 2	2009-04-01
Completed	A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for HIV-1 Infection	Phase 2	2008-11-01
Completed	Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection. HIV Infections	Phase 2	2008-05-01
Completed	Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma Metastatic Melanoma	Phase 1 / Phase 2	2008-03-01
Unknown	Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme Glioblastoma Multiforme	Phase 1 / Phase 2	2008-03-01
Terminated	Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Pr Alzheimer's Disease	Phase 3	2006-09-01
Terminated	Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's Alzheimer Disease, Dementia	Phase 3	2006-05-01
Completed	Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients fo HIV Infections	Phase 2	2006-04-01
Completed	Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases Brain Neoplasms	Phase 1	2005-12-01
Completed	Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors Refractory Solid Tumors	Phase 1	2005-03-01
Completed	Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's Alzheimer Disease, Dementia	Phase 3	2005-02-01
Unknown	R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence Prostate Cancer	Phase 2	2002-02-01